Welcome to LookChem.com Sign In|Join Free

CAS

  • or
FMOC-LEU-GLY-OH is a chemical compound consisting of three amino acids leucine, glycine, and an FMOC (9-fluorenylmethoxycarbonyl) protecting group. It is commonly used in peptide synthesis, where the FMOC group is added to the N-terminal of peptides to protect the amine group from unwanted reactions. Leucine, an essential amino acid, plays a crucial role in protein synthesis and muscle growth and repair. Glycine, the smallest amino acid, is vital for collagen production, which supports skin, bone, and connective tissue health.

82007-05-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 82007-05-4 Structure
  • Basic information

    1. Product Name: FMOC-LEU-GLY-OH
    2. Synonyms: FMOC-LEU-GLY-OH;(9H-Fluoren-9-yl)MethOxy]Carbonyl Leu-Gly-OH
    3. CAS NO:82007-05-4
    4. Molecular Formula: C23H26N2O5
    5. Molecular Weight: 410.46
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 82007-05-4.mol
  • Chemical Properties

    1. Melting Point: 149-150 °C
    2. Boiling Point: 682.5±45.0 °C(Predicted)
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: 1.237±0.06 g/cm3(Predicted)
    6. Refractive Index: N/A
    7. Storage Temp.: -15°C
    8. Solubility: N/A
    9. PKA: 3.39±0.10(Predicted)
    10. CAS DataBase Reference: FMOC-LEU-GLY-OH(CAS DataBase Reference)
    11. NIST Chemistry Reference: FMOC-LEU-GLY-OH(82007-05-4)
    12. EPA Substance Registry System: FMOC-LEU-GLY-OH(82007-05-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 82007-05-4(Hazardous Substances Data)

82007-05-4 Usage

Uses

Used in Pharmaceutical Industry:
FMOC-LEU-GLY-OH is used as a building block for the synthesis of peptide-based drugs. Its unique composition of amino acids and the FMOC protecting group allows for the development of novel therapeutic agents with specific biological activities.
Used in Research and Development:
FMOC-LEU-GLY-OH is utilized in research settings for the study of peptide synthesis, protein structure, and function. Its presence in various peptide sequences enables researchers to investigate the role of specific amino acids in biological processes and the development of new therapeutic strategies.
Used in Peptide Synthesis:
FMOC-LEU-GLY-OH is used as a protected amino acid in the synthesis of peptides. The FMOC group protects the amine group from unwanted side reactions, allowing for the controlled and efficient assembly of peptide chains. This is particularly important in the development of complex peptide-based drugs and biological agents.
Used in Protein Synthesis and Muscle Growth:
Leucine, one of the amino acids in FMOC-LEU-GLY-OH, is an essential component of protein synthesis and plays a significant role in muscle growth and repair. Its presence in the compound contributes to the development of therapeutic agents targeting muscle health and recovery.
Used in Collagen Production and Tissue Support:
Glycine, another amino acid in FMOC-LEU-GLY-OH, is crucial for the production of collagen, a protein that supports skin, bone, and connective tissue. FMOC-LEU-GLY-OH's role in collagen synthesis makes it a valuable component in the development of treatments for various skin and tissue-related conditions.

Check Digit Verification of cas no

The CAS Registry Mumber 82007-05-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,2,0,0 and 7 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 82007-05:
(7*8)+(6*2)+(5*0)+(4*0)+(3*7)+(2*0)+(1*5)=94
94 % 10 = 4
So 82007-05-4 is a valid CAS Registry Number.

82007-05-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-[[(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-methylpentanoyl]amino]acetic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:82007-05-4 SDS

82007-05-4Downstream Products

82007-05-4Relevant articles and documents

Solid-phase peptide synthesis and solid-phase fragment coupling mediated by isonitriles

Wang, Ting,Danishefsky, Samuel J.

, p. 11708 - 11713 (2013/08/23)

The synthesis of polypeptides on solid phase via mediation by isonitriles is described. The acyl donor is a thioacid, which presumably reacts with the isonitrile to generate a thio-formimidate carboxylate mixed anhydride intermediate. Applications of this

Characterization of Nα-Fmoc-protected dipeptide isomers by electrospray ionization tandem mass spectrometry (ESI-MSn): Effect of protecting group on fragmentation of dipeptides

Ramesh,Raju,Srinivas,Sureshbabu,Vishwanatha,Hemantha

, p. 1949 - 1958 (2012/05/20)

A series of positional isomeric pairs of Fmoc-protected dipeptides, Fmoc-Gly-Xxx-OY/Fmoc-Xxx-Gly-OY (Xxx = Ala, Val, Leu, Phe) and Fmoc-Ala-Xxx-OY/Fmoc-Xxx-Ala-OY (Xxx = Leu, Phe) (Fmoc = [(9-fluorenylmethyl) oxy]carbonyl) and Y = CH3/H), have been characterized and differentiated by both positive and negative ion electrospray ionization ion-trap tandem mass spectrometry (ESI-IT-MSn). In contrast to the behavior of reported unprotected dipeptide isomers which mainly produce y 1+ and/or a1+ ions, the protonated Fmoc-Xxx-Gly-OY, Fmoc-Ala-Xxx-OY and Fmoc-Xxx-Ala-OY yield significant b 1+ ions. These ions are formed, presumably with stable protonated aziridinone structures. However, the peptides with Gly- at the N-terminus do not form b1+ ions. The [M + H]+ ions of all the peptides undergo a McLafferty-type rearrangement followed by loss of CO2 to form [M + H-Fmoc + H]+. The MS3 collision-induced dissociation (CID) of these ions helps distinguish the pairs of isomeric dipeptides studied in this work. Further, negative ion MS 3 CID has also been found to be useful for differentiating these isomeric peptide acids. The MS3 of [M-H-Fmoc + H]- of isomeric peptide acids produce c1-, z1 - and y1- ions. Thus the present study of Fmoc-protected peptides provides additional information on mass spectral characterization of the dipeptides and distinguishes the positional isomers. Copyright

'Glycylcyclines'. 3. 9-Aminodoxycyclinecarboxamides

Barden,Buckwalter,Testa,Petersen,Lee

, p. 3205 - 3211 (2007/10/02)

A series of 9-(acylamino)doxycycline derivatives has been prepared. These analogs exhibit good activity against both tetracycline sensitive and tetracycline resistant Gram-positive (Staphylococcus aureus) and Gram- negative (Escherichia coli) bacteria tha

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 82007-05-4